Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Clinical trial NCT04731740 · WITHDRAWN

Trial details

NCT number: NCT04731740
Sponsor: Saint Petersburg State University, Russia
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Thyroid Gland Carcinoma Poorly Differentiated Thyroid Gland Carcinoma Thyroid Gland Anaplastic Carcinoma by AJCC V8 Stage

Start date: 2020-12-28
Primary completion: 2023-12-28
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.